A simple pressure pump, made from balloons and nylon stockings, means more people in more places will be able to test water contaminants and blood samples.
The ingenious device unveiled in the prestigious Lab on a Chip journal cost just $2 to make, yet works almost as well as its expensive and cumbersome lab counterparts.
Pumps are used to make biological samples flow through microfluidic devices while their contents are identified beneath a microscope.
This DIY pump came from a collaboration between researchers at RMIT University and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, who demonstrated its viability in tests to detect aquatic parasites and cancer cells and to study vascular diseases.
Inspired by football
Study lead author and RMIT engineer, Dr Peter Thurgood,said the team took inspiration for the simple invention from footballs, which hold large pressures when reinforced.
“We started with basic latex balloons, then realised that regular stockings made from nylon and elastane could be a perfect match to reinforce them, allowing them to hold significantly higher pressure and function as pumps,” Thurgood said.
“By simply wrapping three layers of stockings around the latex balloon we were able to increase its internal pressure by a factor of 10 – enough to run many water or blood analyses that would usually require large, expensive pumps.”
Experiments showed the reinforced balloon pump could be used to operate microfluidic devices for several hours without a significant pressure loss.
The pump also fits easily within an incubator and can be left overnight.
A low-cost field tool where it’s needed most
Study co-author and parasitologist at the Walter and Eliza Hall Institute,Associate Professor Aaron Jex, is a leading researcher in global water quality and public health interventions.
He said this simple innovation opened exciting opportunities in field water testing and the ability to test and diagnose patients for infectious pathogens and aquatic micro-organisms at the point-of-care.
“Parasitic micro-organisms have a major impact in impoverished communities in tropical and subtropical regions globally, but also in developed countries including Australia,” Jex said.
“In order to address this there is an urgent need for field-based, low-cost diagnostic tools that work in challenging, sometimes remote and often complex environments very different from a pristine laboratory.”
“As simple as it may look, this device suits those needs really well and could have a big impact.”
Co-author and RMIT biologist, Dr Sara Baratchi, said it also had promising applications for early diagnosis of diseases at home or in the doctor’s surgery.
The balloon pump was tested as a point-of-care diagnostic device for detection of very low concentrations of target cancer cells in liquid samples, and found to work.
“The hydrodynamic force of liquid produced by the reinforced balloon was enough to isolate cells for study, which was really amazing for a $2 pump!”
Baratchi is now working on applying the simplified pump technology to develop organ-on-chip systems that mimic the flow conditions in dysfunctional vessels, to better understand diseases like atherosclerosis that lead to heart attack and stroke.
An opportunity for outreach
RMIT engineer and project leader, Dr Khashayar Khoshmanesh,is a leading researcher in the field of microfluidic based lab-on-a-chip technologies.
He said while microfluidics had made significant progress over the past decade, their widespread application had been limited by the cost and bulk of pumps required to operate them.
“Simplicity is at the heart of our entire research program. By redesigning sophisticated microfluidic devices into simplified ones, we can maximise their outreach and applications for use in teaching or research in the field, not just in sophisticated labs,” he said.
“We envisage these types of pumps also being suitable for student classwork experiments to support capability development in this important area of research from an earlier stage.”
The Latest on: Point-of-care diagnostic device
via Google News
The Latest on: Point-of-care diagnostic device
- MRIGlobal to Perform Work On DARPA DIGET Programon January 15, 2021 at 1:00 am
DARPA’s Biological Technologies Office recently awarded the MRIGlobal Team’s proposal to “Detect It with Gene Editing Technologies” (DIGET). DIGET aims to provide next-generation detection for the DOD ...
- i-calQs Smartphone-based diagnostic platform makes rapid testing easy, fast, and inexpensiveon January 15, 2021 at 12:48 am
A new smartphone technology developed by i-calQ, a leader in the emerging mobile bio-diagnostics industry, promises to deliver easy to use, fast and inexpensive point of care diagnostics that will ...
- Narendra Varde appointed as Roche Diagnostics Managing Director India, Neighbouring Marketson January 14, 2021 at 10:44 pm
Roche Diagnostics India, a part of the Roche Group, on Wednesday announced the appointment of Narendra Varde as Managing Director for India and Neighbouring Markets. Varde joins the company from ...
- Cepheid Gets Health Canada License For Four-in-one Rapid Molecular Diagnostic Test - Quick Factson January 14, 2021 at 4:14 am
(DHR), said Thursday that it has received a medical device license from Health Canada for Xpert Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses ...
- Microfluidics Device Market 2020 – Company Profiles, Industry Segments, Landscape and Demand by Forecast to 2024on January 13, 2021 at 10:34 am
A microfluidic device is a well-accepted technology and has several applications. The technology allows integration of ...
- Global Point-of-care Cholesterol Monitoring Device Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2028on January 12, 2021 at 5:33 pm
A recent market study published by the company “Point-of-care Cholesterol Monitoring Device Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” consists a comprehensive ...
- Israeli blood diagnostic solution expands into Scandinaviaon January 12, 2021 at 5:40 am
The Israeli startup kicks off 2021 on a high note, launching point-of-care diagnostic solution in Sweden... Israeli MedTech startup PixCell Medical and its blood-based diagnostic device at ...
- EKF Diagnostics sees performance 'comfortably' ahead of expectations amid ongoing momentumon January 12, 2021 at 12:56 am
StockMarketWire.com - Point-of-care business EKF Diagnostics said it expected annual performance for the year ending 31 December 2020 and for the first quarter of the new to top market. The company ...
- Global Point-of-Care Diagnostics Market Growth, Trends and Forecasts to 2025 - ResearchAndMarkets.comon January 8, 2021 at 10:41 pm
Jan 8, 2021-- The “Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)” report has been added to ResearchAndMarkets.com’s offering. The point-of-care diagnostics market is ...
- Point-of-Care Coagulation Testing Devices Market – Global Insights and Forecast 2020 to 2027on January 8, 2021 at 1:23 am
Vision Research Reports, Latest Report Study on “Point-of-Care Coagulation Testing Devices Market Size, Share, Growth, Trends, Scope, Regional Insights and Forecast 2020 – 2027” The global ...
via Bing News